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The COVID-19 pandemic has renewed interest in endemic human
coronaviruses (HCoV), which are responsible for an estimated 5-10%
of acute respiratory infections (ARI) in temperate climate zones [1].
The epidemiological profiles of these agents may hold important
clues to an anticipated future where SARS-CoV-2 has transitioned to
endemicity [2], as they share physicochemical properties and route
of transmission. However, due to an underappreciation of their clini-
cal and epidemiological impact, systematic surveillance data describ-
ing the epidemiology of endemic coronaviruses NL63, HKU1, OC43
and 229E and their susceptibility to non-pharmaceutical interven-
tions (NPI) are currently sparse. This led us to retrospectively exam-
ine our 2019/20 sample compilation, which was collected for the
purpose of national surveillance of respiratory viruses in Germany as
described earlier [3], providing insight into the epidemiology of
endemic coronavirus infections at the German national scale for the
first time.
A total of 4,375 specimens from children and adults, who had pre-
sented with acute respiratory symptoms to a sentinel physician
between October 2019 and September 2020, were examined by qPCR
[see supplementary information online]. Endemic coronaviruses of
all four types were detected in 194 (4¢4%) of the samples (Figure 1a).
They were detected in all age groups from newborns to the elderly
(Figure 1b). HKU1 was predominant, representing more than 55% of
total coronavirus detections and peaking in December, when almost
8% of all samples contained this virus. The early HKU1 wave was fol-
lowed by a less pronounced NL63 wave, indicating substantial spread
with up to nearly 4% positive results in March. OC43 showed aDOI of original article: http://dx.doi.org/10.1016/j.lanepe.2021.100112.
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slight accentuation in early winter months, and 229E was detected
only sporadically in winter and early spring. The non-pharmaceutical
interventions (NPIs) implemented in March/April 2020 to curb SARS-
CoV-2 spread [3] did appear to contribute to the decrease of endemic
coronavirus detections in April, and only sporadic detections in May
and June were observed throughout the remainder of the season
2019/2020. Our data indicate frequent circulation of endemic human
coronaviruses from late autumn to spring, with a sharp increase in
autumn and peaking from December to April, thus confirming recent
reports on the temporal HCoV circulation patterns in temperate
regions with a clear preponderance during the winter season [1,4,5].
Also, the decrease of virus circulation after the introduction of NPIs is
compatible with the pattern observed for other respiratory viruses,
although other causes cannot be excluded, as discussed earlier [3].
More insight into the natural epidemiology of these agents will be
gained by their systematic surveillance at regional, national and even
global levels in the future.Contributors
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Figure 1. (a) virus detections for the coronavirus types per calendar month and (b) virus detections per predefined AGI age group (* including 30 samples of unknown age group)
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